# Ed Michael

> Ed Michael is a seed investor at LionBird (Chicago) backing Medical and Robotics. See 3 investments, check sizes, portfolio. Updated Aug 2026.

- Type: Angel Investor
- Fund: [LionBird](https://shizune.co/investors/profile/lionbird)
- Location: Chicago, United States
- Total investments: 3
- Last investment: Apr 2025
- Lead investor: 67%
- Last updated: Aug 2026
- LinkedIn: https://www.linkedin.com/in/edward-michael-3a8b0356

Ed Michael is a seed investor at LionBird in Chicago focused on Medical and Robotics. Ed co-founded LionBird following a 25-year career at Abbott Laboratories where he served as Executive Vice President of Diagnostic Products, overseeing over $4B in revenues and 13,000 employees. Previously he held various commercial and operational leadership positions in the company. Ed served on the Board of Directors at Cook County Health andHospitals System from 2012-2013, and currently serves on the Boards of NeuMoDx, a molecular diagnostics company, and several LionBird portfolio companies. He earned his BA in politics and government and a juris doctorate from Indiana University in Bloomington

## Investment focus

### Industry

| Industry | Investments | Share |
| --- | --- | --- |
| Medical | 1 | 33% |
| Robotics | 1 | 33% |
| Wellness | 1 | 33% |
| Health Care | 1 | 33% |
| Neuroscience | 1 | 33% |

8 industries tracked in total.

### Stage

| Stage | Investments | Share |
| --- | --- | --- |
| Seed | 2 | 67% |
| Series A | 1 | 33% |

## Investments

| Company | Description | Amount | Stage | Date | Website |
| --- | --- | --- | --- | --- | --- |
| Phantom Neuro | Phantom Neuro develops innovative muscle-machine interfaces that enhance robotic limb rehabilitation. The company focuses on creating solutions that improve mobility for users by integrating neurotechnology with robotic systems. Through its minimally invasive approach, Phantom Neuro aims to facilitate precise control of robotic limbs, allowing formore natural movement and better user experiences. The company is committed to advancing the field of neurotechnology, providing valuable tools for rehabilitation and improving the quality of life for individuals with mobility challenges. Phantom Neuro also explores various applications of its technologies, contributing to the broader field of assistive robotics. | $19M | Series A | Apr 15, 2025 |  |
| PatientPartner | PatientPartner is creating the first ever defined patient journey. A roadmap to every patient’s healthcare experience that provides a simple step by step process for navigating through any treatment, any procedure, or any condition. By combining artificial intelligence and machine learning with personalized human connections, we are able to createrelatable experiences between patients, providers and industry partners all in once place. Our vision is to create a platform where the world comes to understand their health. A future where all of healthcare can be found on a single platform that is focused on ensuring patients get the care and experiences they deserve. We work with physicians, healthcare institutions and medical technology companies across all healthcare verticals to bring new motivated patients into their clinics, reduce patient drop off, and collect long-term patient outcome data to better identify future patient needs and create better experiences. | $3.5M | Seed | Sep 04, 2024 |  |
| Phantom Neuro | Phantom Neuro develops innovative muscle-machine interfaces that enhance robotic limb rehabilitation. The company focuses on creating solutions that improve mobility for users by integrating neurotechnology with robotic systems. Through its minimally invasive approach, Phantom Neuro aims to facilitate precise control of robotic limbs, allowing formore natural movement and better user experiences. The company is committed to advancing the field of neurotechnology, providing valuable tools for rehabilitation and improving the quality of life for individuals with mobility challenges. Phantom Neuro also explores various applications of its technologies, contributing to the broader field of assistive robotics. | $3.3M | Seed | Mar 25, 2022 |  |

3 of 3 investments shown.

## Co-investors
- [Draper Associates](https://shizune.co/investors/profile/draper-associates-2) — VC Fund, 2 deals together
- [E1 Ventures](https://shizune.co/investors/profile/e1-ventures) — VC Fund, 2 deals together
- [Blackrock Neurotech](https://shizune.co/investors/profile/blackrock-neurotech) — VC Fund, 1 deal together
- [Breakout Ventures](https://shizune.co/investors/profile/breakoutventures) — VC Fund, 1 deal together
- [Brown Advisory](https://shizune.co/investors/profile/brown-advisory) — VC Fund, 1 deal together
- [Capital Factory](https://shizune.co/investors/profile/capital-factory) — VC Fund, 1 deal together

## About LionBird

VC Fund · Tel Aviv, Israel

LionBird is a Tel Aviv- and Chicago-based venture capital firm investing in early-stage software companies operating in the healthcare, commerce, and enterprise sectors. Founded in 2012, LionBird has developed an investment strategy around early-stage startups that leverages online technology to re-imagine traditional offline business processes andmodels.

5 contacts available at LionBird.

| Name | Title | Profile |
| --- | --- | --- |
| Chaim Friedman | Founding Partner | https://shizune.co/investors/profile/chaim-friedman |
| Ed Michael | Managing Partner | https://shizune.co/investors/profile/ed-michael |
| Eric Fenster | Solo Legal Counsel / Partner | https://shizune.co/investors/profile/eric-fenster |
| Gal Noyman Veksler | Principal | https://shizune.co/investors/profile/gal-noyman-veksler |
| Itschak Friedman | Venture Partner | https://shizune.co/investors/profile/itschak-friedman |

## Similar investors

### Similar stage
- [Antler](https://shizune.co/investors/profile/antler-be9c) — VC Fund
- [Alumni Ventures](https://shizune.co/investors/profile/alumni-ventures-group) — VC Fund
- [Right Side Capital Management](https://shizune.co/investors/profile/right-side-capital-management) — VC Fund

## FAQ

### What does Ed Michael invest in?

Ed Michael invests primarily in Medical, Robotics and Wellness startups, most often at Seed and Series A stage. Most of the 3 investments tracked by Shizune back companies in United States. The Investment Focus section breaks down every industry, stage and country in the portfolio.

### When did Ed Michael last invest?

The most recent investment recorded for Ed Michael closed in Apr 2025. Shizune tracks 3 investments in total for this profile, including round sizes, stages and portfolio companies, all sourced from confirmed public funding rounds and refreshed monthly.

### Is Shizune's investor data accurate?

Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Aug 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.

# About Shizune
Shizune.co is an investor database. Core features:
- 48,091 startup investors (angels, VCs, accelerators, and others)
- Email, phone, LinkedIn (for intros), socials, and other contact data
- Updated daily from public funding news
- CSV and Excel export

The User can access the full database FOR FREE after signing up: shizune.co